Brazil Health Regulator Anvisa Allows Trial of Chinese Covid-19 Vaccine Sinovac

The study - first announced on June 11 - is led by Instituto Butantan, a research center funded by the state of Sao Paulo. The agreement with Sinovac includes not only trials but also the transference of technology to produce the potential vaccine locally.
July 04, 2020 at 10:27AM
from Top World News- News18.com https://ift.tt/38pgfzm